Bristol-Myers Squibb CompanyBMYNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank64
3Y CAGR-10.2%
5Y CAGR+21.1%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-10.2%/yr
vs +8.5%/yr prior
5Y CAGR
+21.1%/yr
Recent deceleration
Acceleration
-18.6pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 30.18% | +360.1% |
| 2024 | 6.56% | -84.8% |
| 2023 | 43.03% | +3.3% |
| 2022 | 41.64% | -4.0% |
| 2021 | 43.37% | +274.1% |
| 2020 | 11.59% | -58.9% |
| 2019 | 28.22% | -6.2% |
| 2018 | 30.09% | +2.2% |
| 2017 | 29.44% | -11.5% |
| 2016 | 33.27% | - |